Construction of a Prefabricated Modular Building for a Thermal Disinfection and Decontamination Station for Pathogenicity Groups III–IV Effluents

INEX Group is an active contributor to one of Russia’s most ambitious healthcare infrastructure projects: the construction of the SOGAZ Multidisciplinary Medical Complex (MMC) in St. Petersburg. This 140,000 m² facility features a full-cycle oncology center, a rehabilitation hub, and a cutting-edge Nuclear Medicine Research Center developed in partnership with the Kurchatov Institute for the synthesis of isotope-based radiopharmaceuticals.

Commissioned by the General Contractor, ENKA (ENKA İnşaat ve Sanayi A.Ş.), INEX was tasked with engineering the decontamination sector for effluents categorized under Pathogenicity Groups III-IV.

To meet the project's rigorous safety requirements, INEX developed the proprietary UTOS-1-500 Effluent Decontamination System. This unit is specifically engineered for the continuous thermal treatment of infected liquid waste.

Technical Specifications of the UTOS-1-500:

• Operational Method: Continuous high-temperature thermal sterilization.

• Cycle Management: Integrated systems for the accumulation, storage, neutralization, and controlled discharge of decontaminated fluids.

• Throughput: Minimum capacity of 2.5 m³ per day.

• Safety Integration: Fully enclosed loop to prevent aerosolization or leakage of pathogenic agents prior to treatment.

The implementation of the UTOS-1-500 provides a turnkey solution for the biological safety of the SOGAZ medical cluster, allowing for the safe discharge of treated water into municipal sewage networks.

Regulatory Compliance (RF)

The engineering design and the UTOS-1-500 system comply with the following mandatory regulatory frameworks:

• SanPiN 3.3686-21: "Sanitary and Epidemiological Requirements for the Prevention of Infectious Diseases" (specifically regarding the management of hazardous biological waste).

• SP 158.13330.2014: Design standards for medical organization buildings and premises.

• GMP Standards: Maintaining process integrity within the associated radiopharmaceutical research laboratories.